Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 2Colonic Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Rectal Neoplasms 1Polycystic Ovary Syndrome 1Neuroendocrine Tumors 1Neoplasms 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphangioleiomyomatosis 1Liver Neoplasms 1Gastro-enteropancreatic neuroendocrine tumor 1Chemoprevention 1Carcinoma, Hepatocellular 1

Interventions

Resveratrol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Chemoprevention × Resveratrol × Clear all
NCT04266353 2023-05-09

Effect of Resveratrol on Serum IGF2 Among African American Women

Loma Linda University

Phase NA Withdrawn

Chemoprevention

Data powered by HemOnc (CC BY 4.0) Colophon âš¡